All reports
Pharmaceutical
Biosimilars & Generics
Biosimilars: FDA Streamlined Pathway
Code: NSC/PHRM/0016Published Apr 01, 2026
About this report
October 2025 FDA guidance streamlining biosimilarity studies; impact on time-to-market.
Humans at the core of the analysis
Partner specialist firms, independent domain experts and our in-house analyst team: every report is written and reviewed by humans who cross-check signals, verify sources and prioritise what matters.
Key insights
Request the sample to discover the report's key insights.
Table of contents
The detailed table of contents is shared with the free sample.